Brian I. Rini - Articles and news items

Pfizer logo

U.S. Food and Drug Administration approves Pfizer’s INLYTA® (axitinib)

Industry news, News / 27 January 2012 / Pfizer

First treatment to demonstrate superior benefit in a Phase 3 study compared with another targeted agent in advanced RCC…

Pfizer logo

Pfizer presents new Phase 3 data

Industry news, News / 18 May 2011 / Pfizer

Pfizer Inc. announced data from the pivotal Phase 3 AXIS 1032 trial. Patients with previously treated advanced RCC, axitinib extended progression-free survival…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...